medmix AG engages in the business of design and production of delivery devices and applicators for the dental, drug delivery, surgery, industrial, and beauty markets. The company is headquartered in Baar, Zug and currently employs 2,667 full-time employees. The company went IPO on 2021-09-30. The firm operates through two reportable segments: Healthcare along with Consumer and Industrial. Healthcare segment includes design and production of high-precision delivery devices and services within drug delivery, surgery and dental markets. Products include injection pens, surgical delivery devices focusing on trauma bone repair and wound healing tissue treatment and mixing, filling and delivery device systems for the dental consumable industry. Consumer and Industrial segment consists of design and production of high precision delivery devices within industry business unit, this includes adhesives used in construction, electronics, automotive, aerospace and various industries, and consumer markets such as beauty and other microbrush applications.
Follow-Up Questions
medmix AG のCEOは誰ですか？
Dr. Rene Willi は medmix AG の Chief Executive Officer で、2022 から在籍しています。
MDMXF の株価パフォーマンスは？
MDMXF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
medmix AG の主な事業テーマや業界は？
medmix AG は Health Care 業界、セクターは Health Care に属しています。
